Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1995 1
1997 1
2000 2
2001 2
2002 2
2003 2
2005 3
2006 2
2007 1
2008 1
2009 3
2010 2
2011 6
2012 2
2013 5
2014 8
2015 4
2016 10
2017 8
2018 1
2019 4
2020 11
2021 7
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors.
Xu C, Zhang Y, Wang W, Wang Q, Li Z, Song Z, Wang J, Yu J, Liu J, Zhang S, Cai X, Wu M, Zhan P, Liu H, Lv T, Miao L, Min L, Li J, Liu B, Yuan J, Jiang Z, Lin G, Chen X, Pu X, Rao C, Lv D, Yu Z, Li X, Tang C, Zhou C, Zhang J, Guo H, Chu Q, Meng R, Liu X, Wu J, Hu X, Fang M, Zhou J, Zhu Z, Chen X, Pan W, Pang F, Zhou Y, Jian Q, Wang K, Wang L, Zhu Y, Yang G, Lin X, Cai J, Liang L, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Huang J, Zhang Y, Sun P, Wang H, Ye M, Wang D, Wang Z, Hao Y, Wang Z, Wan B, Lv D, Yu G, Li A, Kang J, Zhang J, Zhang C, Chen H, Shi L, Ye L, Wang G, Wang Y, Gao F, Zhou W, Hu C, Wei J, Li B, Li Z, Li Y, Liu Z, Yang N, Wu L, Wang Q, Huang W, Hong Z, Wang G, Fang M, Fang Y, Zhu X, Du K, Ji J, Shen Y, Zhang Y, Ma S, Song Y, Lu Y, Liu A, Fang W, Zhong W. Xu C, et al. Thorac Cancer. 2023 Apr;14(12):1102-1117. doi: 10.1111/1759-7714.14847. Epub 2023 Mar 16. Thorac Cancer. 2023. PMID: 36924056 Free PMC article.
Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. ...Treatment for advanced, unresectable TETs consist mainly of radiotherapy and chemotherapy, but there is a lack of standard first- and second-line tre
Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. ...Treatment
Thymic Malignancy-Updates in Staging and Management.
Rappaport JMP, Huang J, Ahmad U. Rappaport JMP, et al. Surg Oncol Clin N Am. 2020 Oct;29(4):581-601. doi: 10.1016/j.soc.2020.06.010. Epub 2020 Aug 11. Surg Oncol Clin N Am. 2020. PMID: 32883460 Review.
Thymomas are relatively indolent tumors that present with locally advanced disease in 30% of the patients. Thymic carcinoma is a more aggressive histology with shorter disease-free and overall survival. Early-stage tumors are managed best with complete resection. Mu …
Thymomas are relatively indolent tumors that present with locally advanced disease in 30% of the patients. Thymic carcinoma is …
Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Clinical Practice Guideline.
Falkson CB, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E. Falkson CB, et al. J Thorac Oncol. 2022 Nov;17(11):1258-1275. doi: 10.1016/j.jtho.2022.08.007. Epub 2022 Aug 27. J Thorac Oncol. 2022. PMID: 36031176 Free article. Review.
INTRODUCTION: The aim of this guideline was to provide recommendations for the most effective therapy for patients with thymic epithelial tumors, including thymoma, thymic carcinoma, and thymic neuroendocrine tumors (NETs). This guideline is int …
INTRODUCTION: The aim of this guideline was to provide recommendations for the most effective therapy for patients with thymic
Novel Agents in the Treatment of Thymic Malignancies.
Merveilleux du Vignaux C, Maury JM, Girard N. Merveilleux du Vignaux C, et al. Curr Treat Options Oncol. 2017 Aug 10;18(9):52. doi: 10.1007/s11864-017-0495-8. Curr Treat Options Oncol. 2017. PMID: 28795288 Review.
Recurrences of thymic epithelial tumors should be managed according to the same strategy as newly diagnosed tumors. Given the limited activity of cytotoxic agents in the advanced, refractory setting, novel and innovative agents are needed. The better understanding of th
Recurrences of thymic epithelial tumors should be managed according to the same strategy as newly diagnosed tumors. Given the limited …
An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors.
Agrafiotis AC, Berzenji L, Koyen S, Vermeulen D, Winthagen R, Hendriks JMH, Van Schil PE. Agrafiotis AC, et al. Int J Mol Sci. 2023 Dec 2;24(23):17065. doi: 10.3390/ijms242317065. Int J Mol Sci. 2023. PMID: 38069386 Free PMC article. Review.
Angiogenesis significantly influences the carcinogenesis of thymic epithelial tumors (TET). Both thymomas and thymic carcinoma (TC) overexpress VEGF-A and VEGFR-1 and -2. ...The current evidence suggests that the most active agent is lenvatinib, whereas sunit …
Angiogenesis significantly influences the carcinogenesis of thymic epithelial tumors (TET). Both thymomas and thymic carcin
Advances in thymic carcinoma diagnosis and treatment: a review of literature.
Syrios J, Diamantis N, Fergadis E, Katsaros L, Logothetis M, Iakovidou I, Lianos E, Grivas A, Athanasiou AE. Syrios J, et al. Med Oncol. 2014 Jul;31(7):44. doi: 10.1007/s12032-014-0044-2. Epub 2014 Jun 7. Med Oncol. 2014. PMID: 24906655 Review.
Due to the rarity of thymic carcinoma and the great variety of its histological subtypes, there is no solid evidence on optimal staging, imaging and treatment guidelines. Herein, we systematically review the literature on current clinical practice with regard to dia …
Due to the rarity of thymic carcinoma and the great variety of its histological subtypes, there is no solid evidence on optima …
Precise Diagnosis and Treatment of Thymic Epithelial Tumors Based on Molecular Biomarkers.
Du J, Zhou XJ. Du J, et al. Crit Rev Oncog. 2017;22(5-6):507-514. doi: 10.1615/CritRevOncog.2017020577. Crit Rev Oncog. 2017. PMID: 29604928 Review.
Thymic epithelial tumors (TETs), including thymoma and thymic carcinoma, are rare malignant tumors. ...However, for those patients who are resistant to chemotherapy, targeted therapy has become the most popular tumor treatment program, as well as for
Thymic epithelial tumors (TETs), including thymoma and thymic carcinoma, are rare malignant tumors. ...However, for tho
American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma.
Chun SG, Rimner A, Amini A, Chang JY, Donington J, Edelman MJ, Geng Y, Gubens MA, Higgins KA, Iyengar P, Movsas B, Ning MS, Park HS, Rodrigues G, Wolf A, Simone CB 2nd. Chun SG, et al. JAMA Oncol. 2023 Jul 1;9(7):971-980. doi: 10.1001/jamaoncol.2023.1175. JAMA Oncol. 2023. PMID: 37186595 Review.
IMPORTANCE: Thymic carcinoma is rare, and its oncologic management is controversial due to a paucity of prospective data. ...OBJECTIVE: To develop expert multidisciplinary consensus guidelines on the management of common presentations of thymic carcinoma
IMPORTANCE: Thymic carcinoma is rare, and its oncologic management is controversial due to a paucity of prospective data. ...O …
Thymoma versus thymic carcinoma: differences in biology impacting treatment.
Kelly RJ. Kelly RJ. J Natl Compr Canc Netw. 2013 May 1;11(5):577-83. doi: 10.6004/jnccn.2013.0073. J Natl Compr Canc Netw. 2013. PMID: 23667207 Review.
Genomic profiling distinguishes type B3 thymoma and thymic carcinoma from type A and B2 thymomas. Furthermore, type B2 thymomas can be separated from other subgroups in that it has a more distinctly lymphocytic component than the other groups in which epithelial cel …
Genomic profiling distinguishes type B3 thymoma and thymic carcinoma from type A and B2 thymomas. Furthermore, type B2 thymoma …
An Updated Review on Radiation Treatment Management in Thymus Cancers.
Liu J, Govindarajan A, Williams TM, Kim J, Erhunmwunsee L, Raz D, Massarelli E, Salgia R, Chen YJ, Amini A. Liu J, et al. Clin Lung Cancer. 2022 Nov;23(7):561-570. doi: 10.1016/j.cllc.2022.07.004. Epub 2022 Jul 21. Clin Lung Cancer. 2022. PMID: 35941046 Review.
We performed a systematic search of the MEDLINE/PubMed database, focusing on studies published within the last 30 years. Our search queried "thymoma [OR] thymic carcinoma [AND] radiation" and was limited only to prospective and retrospective studies and metanalyses, …
We performed a systematic search of the MEDLINE/PubMed database, focusing on studies published within the last 30 years. Our search queried …
89 results